To our knowledge, the expression pattern suggest that the progression into aggressive cancer stages is due to the loss of anti-cancer effect via suppression of the expression of TNFR1 and IL-32α, and the cell death signaling of TNFR1. The gene discussed is TNFRSF1A; the disease is cancer.